Maximising Returns from Life Science Innovation | 4 December 2024 | London, UK

One Nucleus and Life Science Nation unite for Genesis 2024 and Redefining Early Stage Investments (RESI) Conferences

One Nucleus and Life Science Nation unite for the Genesis 2024 and Redefining Early Stage Investments (RESI) Conferences to Amplify Impact on Life Science Innovation

Boston MA and London UK, 31 July 2024 – One Nucleus and Life Science Nation (LSN) are pleased to announce the co-location of their renowned Genesis 2024 and Redefining Early Stage Investments (RESI) conferences, scheduled to take place on 4 December 2024, in London. The Genesis Conference programme will be at 1 Wimpole Street, and RESI will be at 11 Cavendish Square, allowing attendees to participate in either or both events just a few steps away from each other. This unprecedented collaboration aims to connect early-stage life science companies to LSN’s global network of capital investors and licensing partners under the theme of “Maximising Returns from Life Science Innovation.”

For over two decades, the Genesis Conference has been a cornerstone event, bringing together top opinion leaders and stakeholders in life sciences to discuss critical trends, catalyse partnerships, and shape the industry’s future landscape. With its rich history of fostering innovation and facilitating meaningful connections, Genesis has consistently delivered high-value content through keynote presentations, panels, and networking opportunities.

LSN’s RESI conference series is known for being able to match up startup companies seeking seed funds up to 2 million, series A and series B, with global partners. RESI complements Genesis by focusing on early-stage companies and their interaction with investors and partners across the “4 Ds” of Drugs, Devices, Diagnostics, and Digital Health. Integrating RESI’s expertise in matchmaking and Genesis’s comprehensive content programme, the co-located events promise an unparalleled experience for UK delegates and RESI international investors interested in the early-stage assets coming out of locations including Cambridge, London and Oxford.

Key highlights of the co-located conferences include:

  • A diverse mix of high-content keynote presentations and expert panels addressing cutting-edge industry topics.
  • A dedicated RESI interactive partnering, offering both in-person and virtual days that match startups based on the stage of development and product with investors and licensing partners that are the right fit.
  • A dedicated Genesis 2024 Conference App where information is shared, connections are made and is the route to access 1-2-1 Genesis partnering, programme, sponsor, and exhibitor details.
  • Extensive networking opportunities with over 500 industry delegates expected to attend these events, making this one of Europe’s largest life science investor meetings in 2024.
  • Genesis Fringe events offer deeper technical and business insights and enhanced in-person networking.
  • An Exhibition providing a dynamic forum for dialogue and visibility among partners and customers.
  • 20 Innovator’s Pitch Challenge (IPC) slots available. The IPC allows early-stage life science and healthcare companies to engage more with conference attendees and pitch directly to a panel of active investors and industry experts. Applications to apply are open until Friday 25 October.


“We are thrilled to bring together the RESI global investor network with Genesis, a One Nucleus flagship UK event which will add some excitement and facilitate some foreign investment into the life science ecosystem,” said Dennis Ford, CEO of Life Science Nation. “The co-location of  the two conferences represents a significant milestone in fostering collaboration and innovation across the life sciences sector, enabling us to amplify our impact on early-stage companies and investors globally.”

Tony Jones, CEO of One Nucleus, added, “Genesis has always been about shaping the future of life sciences through meaningful dialogue and strategic partnerships. Teaming up with RESI allows us to expand these efforts, creating synergies that benefit our members and the broader life sciences community.”

For more information about the RESI and Genesis conferences, including sponsorship opportunities and registration details, please visit RESI and genesisconference.com.

About Life Science Nation (LSN): Life Science Nation (LSN) is a global partnering ecosystem connecting early-stage companies with investors and partners across Drugs, Devices, Diagnostics, and Digital Health. LSN curates databases of global investors and technology assets, providing sourcing, ranking, and accelerator services through initiatives like RESI and Focus on Cures Accelerator (FOC).

About One Nucleus: One Nucleus is an international membership organisation for life science and healthcare companies. Based in Cambridge, UK, One Nucleus supports its members through networking, knowledge-sharing, and advocacy initiatives, promoting growth and innovation within the life sciences community.

Media Contact Information: 

Media Contacts:
Caitlin Dolegowski, Marketing Manager
c.dolegowski@lifesciencenation.com

Tony Jones, CEO
tony@onenucleus.com

For Conference Inquiries:
Genesis: Claire Abrams – genesis@onenucleus.com
RESI: Claire Jeong – c.jeong@lifesciencenation.com